Forschungszentrum Jülich is a member of the Helmholtz Association of German Research Centres and is one of the largest interdisciplinary research centres in Europe.

During the past decade, Forschungszentrum Jülich conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Forschungszentrum Jülich" #1 collaborator was "Fundación Teófilo Hernando, Spain" with 2 trials as a collaborator, "Helmholtz-Gemeinschaft Deutscher Forschungszentren, Germany" with 2 trials as a collaborator, "Medical University of Vienna" with 2 trials as a collaborator, "NeuroScios, Austria" with 2 trials as a collaborator and "Alzheimer's Association" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Forschungszentrum Jülich" are "Alzheimer Dementia" (2 trials) and "Alzheimer Disease" (2 trials). Many other conditions were trialed in "Forschungszentrum Jülich" in a lesser frequency.

Most popular intervention types in "Forschungszentrum Jülich" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Contraloid" (2 trials). Other intervention names were less common.

The vast majority of trials in "Forschungszentrum Jülich" are 1 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Forschungszentrum Jülich". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Forschungszentrum Jülich, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Forschungszentrum Jülich, 2 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".